Amarantus Announces Positive Preclinical Data on the Effects of MANF on Vision in a Model of Retinitis Pigmentosa
| Tuesday, November 25, 2014 8:31 AM |

[at noodls] - SAN FRANCISCO and GENEVA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutic products ...

http://us.rd.yahoo.com/finance/external/noodl...EE6BDE9839

~ This Week's OTC News In Review! ~

Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html


~ http://www.fallenheroesfund.org/ ~
St. Jude 2014 Drive has started >> http://tinyurl.com/St-Jude-2014